BRIEF-CVS Says CVS Caremark To Add Zepbound To Commercial Formularies As Additional Preferred Option On Oct 1

CVS Health Corporation
Eli Lilly and Company

CVS Health Corporation

CVS

0.00

Eli Lilly and Company

LLY

0.00

May 28 (Reuters) - CVS Health Corp CVS.N:

  • CVS CAREMARK DELIVERS AFFORDABILITY AND ACCESS TO GLP-1 WEIGHT MANAGEMENT MEDICATIONS WITH EXPANDED COVERAGE OPTIONS

  • CVS HEALTH: CVS CAREMARK TO REMOVE NEW-TO-MARKET BLOCK ON FOUNDAYO EFFECTIVE JUNE 1

  • CVS HEALTH: CVS CAREMARK TO ADD ZEPBOUND TO COMMERCIAL FORMULARIES AS ADDITIONAL PREFERRED OPTION ON OCT 1


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.